These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25373013)

  • 1. Higher levels of circulating chemerin in both lean and obese patients with polycystic ovary syndrome.
    Ademoglu E; Berberoglu Z; Carlioglu A; Dellal F; Gorar S; Alphan Z; Uysal S; Karakurt F
    Minerva Ginecol; 2014 Dec; 66(6):535-42. PubMed ID: 25373013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
    Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
    Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome.
    Guzel EC; Celik C; Abali R; Kucukyalcin V; Celik E; Guzel M; Yilmaz M
    Gynecol Endocrinol; 2014 Jun; 30(6):419-22. PubMed ID: 24524360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome.
    Guvenc Y; Var A; Goker A; Kuscu NK
    J Int Med Res; 2016 Aug; 44(4):796-805. PubMed ID: 27225862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome.
    Kort DH; Kostolias A; Sullivan C; Lobo RA
    Gynecol Endocrinol; 2015 Feb; 31(2):152-5. PubMed ID: 25295622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum chemerin concentrations in patients with polycystic ovary syndrome: Relationship between insulin resistance and ovarian volume.
    Huang R; Yue J; Sun Y; Zheng J; Tao T; Li S; Liu W
    Clin Chim Acta; 2015 Oct; 450():366-9. PubMed ID: 26387454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased chemerin serum levels in hyperandrogenic and normoandrogenic women from Argentina with polycystic ovary syndrome.
    Abruzzese GA; Gamez J; Belli SH; Levalle OA; Mormandi E; Otero P; Graffigna MN; Cerrone GE; Motta AB
    Gynecol Endocrinol; 2020 Dec; 36(12):1057-1061. PubMed ID: 32496833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum chemerin level in women with PCOS and its relation with the risk of spontaneous abortion.
    Yang X; Quan X; Lan Y; Wei Q; Ye J; Yin X; Ji Z; Xing H; Yang Y
    Gynecol Endocrinol; 2018 Oct; 34(10):864-867. PubMed ID: 29658354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum chemerin in Chinese women with hyperandrogenic PCOS.
    Wang L; Zhong Y; Ding Y; Shi X; Huang J; Zhu F
    Gynecol Endocrinol; 2014 Oct; 30(10):746-50. PubMed ID: 24927079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome.
    de Medeiros SF; de Medeiros MAS; Barbosa BB; Yamamoto MMW
    Metab Syndr Relat Disord; 2021 Feb; 19(1):18-25. PubMed ID: 32845813
    [No Abstract]   [Full Text] [Related]  

  • 12. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
    Durmus U; Duran C; Ecirli S
    J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between glomerular filtration rate, and metabolic and inflammatory parameters in obese and non-obese patients with polycystic ovary syndrome.
    Can M; Duran C; Guney I; Elmas H; Ayhan M; Erdem SS
    Clin Investig Arterioscler; 2020; 32(6):256-262. PubMed ID: 32773256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of polycystic ovary syndrome and body mass index on the absorption of recombinant human follicle stimulating hormone.
    Lee MS; Lanes A; Dolinko AV; Bailin A; Ginsburg E
    J Assist Reprod Genet; 2020 Sep; 37(9):2293-2304. PubMed ID: 32623663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J; Bergh T; Berne C; Lithell H
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.
    Silfen ME; Denburg MR; Manibo AM; Lobo RA; Jaffe R; Ferin M; Levine LS; Oberfield SE
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4682-8. PubMed ID: 14557441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
    Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
    J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of betatrophin with metabolic characteristics in overweight/obese and lean women with PCOS.
    Li L; Zhang F; Cui J; Shi Y; Xiang J; Wang X; Zhao N; Yan Q; Greenberg AS; Peng Y; Ding X
    Gynecol Endocrinol; 2017 Mar; 33(3):238-243. PubMed ID: 27960599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In overweight/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls.
    Economou F; Xyrafis X; Livadas S; Androulakis II; Argyrakopoulou G; Christakou CD; Kandaraki E; Palioura E; Diamanti-Kandarakis E
    Hormones (Athens); 2009; 8(3):199-206. PubMed ID: 19671519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Coagulation and Decreased Fibrinolysis as Measured with Overall Hemostatic Potential Are Dependent on BMI and Not Associated with PCOS.
    Rakusa M; Jensterle M; Božič-Mijovski M; Janez A
    Metab Syndr Relat Disord; 2017 May; 15(4):194-198. PubMed ID: 28287900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.